vs

Side-by-side financial comparison of PROASSURANCE CORP (PRA) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.

PROASSURANCE CORP is the larger business by last-quarter revenue ($269.6M vs $223.8M, roughly 1.2× SILVERCORP METALS INC). PROASSURANCE CORP runs the higher net margin — 12.4% vs -1.3%, a 13.7% gap on every dollar of revenue. Over the past eight quarters, SILVERCORP METALS INC's revenue compounded faster (87.6% CAGR vs -2.7%).

ProAssurance Corporation, headquartered in Birmingham, Alabama, is a property and casualty company that sells professional liability insurance to doctors. The company was founded in 1976 as Mutual Assurance and was later renamed to Medical Assurance in 1997. The name "ProAssurance" was created in 2001 when Medical Assurance merged with Professionals Group. The company is currently the fourth largest medical professional liability insurance writer and has over $6 billion in assets.

Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.

PRA vs SVM — Head-to-Head

Bigger by revenue
PRA
PRA
1.2× larger
PRA
$269.6M
$223.8M
SVM
Higher net margin
PRA
PRA
13.7% more per $
PRA
12.4%
-1.3%
SVM
Faster 2-yr revenue CAGR
SVM
SVM
Annualised
SVM
87.6%
-2.7%
PRA

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PRA
PRA
SVM
SVM
Revenue
$269.6M
$223.8M
Net Profit
$33.4M
$-2.9M
Gross Margin
Operating Margin
17.3%
Net Margin
12.4%
-1.3%
Revenue YoY
-7.1%
Net Profit YoY
106.4%
EPS (diluted)
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRA
PRA
SVM
SVM
Q4 25
$269.6M
$223.8M
Q3 25
$279.6M
Q2 25
$276.8M
$72.2M
Q1 25
$272.1M
Q4 24
$290.1M
$172.5M
Q3 24
$285.3M
$114.0M
Q2 24
$290.4M
$60.0M
Q1 24
$284.7M
Net Profit
PRA
PRA
SVM
SVM
Q4 25
$33.4M
$-2.9M
Q3 25
$1.4M
Q2 25
$21.9M
$28.1M
Q1 25
$-5.8M
Q4 24
$16.2M
$42.1M
Q3 24
$16.4M
$28.0M
Q2 24
$15.5M
$13.2M
Q1 24
$4.6M
Operating Margin
PRA
PRA
SVM
SVM
Q4 25
17.3%
Q3 25
1.6%
Q2 25
9.9%
Q1 25
-2.3%
Q4 24
6.5%
30.5%
Q3 24
7.4%
30.7%
Q2 24
6.2%
30.0%
Q1 24
1.9%
Net Margin
PRA
PRA
SVM
SVM
Q4 25
12.4%
-1.3%
Q3 25
0.5%
Q2 25
7.9%
39.0%
Q1 25
-2.1%
Q4 24
5.6%
24.4%
Q3 24
5.8%
24.5%
Q2 24
5.3%
22.0%
Q1 24
1.6%
EPS (diluted)
PRA
PRA
SVM
SVM
Q4 25
$0.65
Q3 25
$0.03
Q2 25
$0.42
Q1 25
$-0.11
Q4 24
$0.32
Q3 24
$0.32
Q2 24
$0.30
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRA
PRA
SVM
SVM
Cash + ST InvestmentsLiquidity on hand
$36.5M
Total DebtLower is stronger
$420.4M
Stockholders' EquityBook value
$1.3B
Total Assets
$5.4B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRA
PRA
SVM
SVM
Q4 25
$36.5M
Q3 25
$54.5M
Q2 25
$41.6M
Q1 25
$43.5M
Q4 24
$54.9M
Q3 24
$45.3M
Q2 24
$36.9M
Q1 24
$65.4M
Total Debt
PRA
PRA
SVM
SVM
Q4 25
$420.4M
Q3 25
$421.5M
Q2 25
$422.6M
Q1 25
$423.7M
Q4 24
$424.9M
Q3 24
$425.9M
Q2 24
$426.9M
Q1 24
$427.8M
Stockholders' Equity
PRA
PRA
SVM
SVM
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.1B
Q1 24
$1.1B
Total Assets
PRA
PRA
SVM
SVM
Q4 25
$5.4B
Q3 25
$5.6B
Q2 25
$5.5B
Q1 25
$5.5B
Q4 24
$5.6B
Q3 24
$5.7B
Q2 24
$5.6B
Q1 24
$5.7B
Debt / Equity
PRA
PRA
SVM
SVM
Q4 25
0.31×
Q3 25
0.32×
Q2 25
0.33×
Q1 25
0.34×
Q4 24
0.35×
Q3 24
0.35×
Q2 24
0.38×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRA
PRA
SVM
SVM
Operating Cash FlowLast quarter
$-25.6M
$107.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.77×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRA
PRA
SVM
SVM
Q4 25
$-25.6M
$107.9M
Q3 25
$27.2M
Q2 25
$-28.1M
$40.0M
Q1 25
$-11.6M
Q4 24
$-10.7M
$81.3M
Q3 24
$14.0M
$57.7M
Q2 24
$-12.8M
$28.9M
Q1 24
$-11.6M
Free Cash Flow
PRA
PRA
SVM
SVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$33.8M
Q2 24
$17.0M
Q1 24
FCF Margin
PRA
PRA
SVM
SVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
29.6%
Q2 24
28.3%
Q1 24
Capex Intensity
PRA
PRA
SVM
SVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
21.0%
Q2 24
19.8%
Q1 24
Cash Conversion
PRA
PRA
SVM
SVM
Q4 25
-0.77×
Q3 25
18.81×
Q2 25
-1.28×
1.42×
Q1 25
Q4 24
-0.66×
1.93×
Q3 24
0.85×
2.06×
Q2 24
-0.83×
2.19×
Q1 24
-2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRA
PRA

Workers Compensation Insurance Segment$164.4M61%
Other$59.6M22%
Segregated Portfolio Cell Reinsurance$45.7M17%

SVM
SVM

Segment breakdown not available.

Related Comparisons